Celyad publishes additional pre-clinical data in support of THINK trialGlobeNewswire (press release)MONT-SAINT-GUIBERT, Belgium, June 21, 2017 (GLOBE NEWSWIRE) — Celyad SA (EURONEXT Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a leader in the discovery … Continue reading
Celyad publishes additional pre-clinical data in support of THINK trialGlobeNewswire (press release)MONT-SAINT-GUIBERT, Belgium, June 21, 2017 (GLOBE NEWSWIRE) — Celyad SA (EURONEXT Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a leader in the discovery … Continue reading
Intellia to win China patent for CRISPRBSI bureau (press release)Intellia holds rights to CRISPR intellectual property developed by the Regents of the University of California (UC), the University of Vienna, and Emmanuelle Charpentier, Ph.D., a directo… Continue reading
Labiotech.eu (blog)Check Out these 42 European SynBio Startups Reimagining the IndustryLabiotech.eu (blog)Synthetic biology, or synbio for short, is rapidly infiltrating multiple fields. From bioplastics to food technology and healthcare, these are the… Continue reading
Daily Californian |
China will grant CRISPR patent to UC
Daily Californian China’s State Intellectual Property Office, or SIPO, announced Monday that it will grant the University of California, in conjunction with the University of Vienna and Emmanuelle Charpentier, a patent for its CRISPR gene-editing technology. China’s … Intellia to win China patent for CRISPRBSI bureau (press release) |
Drug Discovery & Development |
Cell Medica Acquires WT1 Cancer Immunotherapy from CGT Catapult
Drug Discovery & Development Cell Medica announced the acquisition of Catapult Therapy TCR Limited, a subsidiary of Cell and Gene Therapy Catapult (CGT Catapult), and the initiation of a collaboration to establish cell therapy manufacturing for Cell Medica at CGT Catapult’s GMP … |
Financial Express |
How LifeCell became the most accredited stem cell bank in India
Financial Express Chennai-based LifeCell, the provider of preventive healthcare services for family wellness, is the world’s second-largest provider of umbilical cord stem cells. Founded in 2004, the company has technological collaboration with the US-based Cryo-Cell … |